Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2008-04-01 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROUBAIX (59100), Nord
GRANDE PHARMACIE DE ROUBAIX : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE ROUBAIX is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROUBAIX (59100),
this company of category PME
shows in 2022 a revenue of 2.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DE ROUBAIX (SIREN 504494048)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 547 369 €
N/C
N/C
N/C
N/C
N/C
1 854 348 €
Net income
115 164 €
133 730 €
244 594 €
291 151 €
191 530 €
192 581 €
197 740 €
158 507 €
170 741 €
EBITDA
N/C
N/C
324 890 €
N/C
N/C
N/C
N/C
N/C
311 840 €
Net margin
N/C
N/C
9.6%
N/C
N/C
N/C
N/C
N/C
9.2%
Revenue and income statement
In 2024, GRANDE PHARMACIE DE ROUBAIX generates positive net income of 115 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 171 k€ -> 115 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
115 164 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 34%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
34.267%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.672%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DE ROUBAIX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
99.946
92.63
126.302
104.621
87.473
63.096
51.587
44.735
34.267
Financial autonomy
42.716
44.318
39.065
40.829
43.208
47.466
55.859
59.124
64.672
Repayment capacity
2.417
None
None
None
None
None
1.701
None
None
Cash flow / Revenue
11.333%
None%
None%
None%
None%
None%
9.796%
None%
None%
Sector positioning
Debt ratio
34.272024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good
In 2024, the debt ratio of GRANDE PHARMACIE DE ROUBAIX (34.27) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.67%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+8 pts over 3 years
In 2024, the financial autonomy of GRANDE PHARMACIE DE ROUBAIX (64.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
1.7 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of GRANDE PHARMACIE DE ROUBAIX (1.70) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 361.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
361.258
Liquidity indicators evolution GRANDE PHARMACIE DE ROUBAIX
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
305.278
312.494
350.441
248.577
216.76
207.384
264.744
336.012
361.258
Interest coverage
13.274
None
None
None
None
None
1.185
None
None
Sector positioning
Liquidity ratio
361.262024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of GRANDE PHARMACIE DE ROUBAIX (361.26) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.19x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of GRANDE PHARMACIE DE ROUBAIX (1.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution GRANDE PHARMACIE DE ROUBAIX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
226 564 €
0 €
0 €
0 €
0 €
0 €
307 416 €
0 €
0 €
Inventory turnover (days)
39
0
0
0
0
0
40
0
0
Customer payment term (days)
8
0
0
0
0
0
5
0
0
Supplier payment term (days)
30
0
0
0
0
0
28
0
0
Positioning of GRANDE PHARMACIE DE ROUBAIX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of GRANDE PHARMACIE DE ROUBAIX is estimated at
1 607 774 €
(range 1 119 628€ - 2 405 322€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1119k€1607k€2405k€
1 607 774 €Range: 1 119 628€ - 2 405 322€
NAF 5 année 2024
Valuation method used
Net Income Multiple
115 164 €
×
14.0x
=1 607 775 €
Range: 1 119 629€ - 2 405 323€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE ROUBAIX with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE ROUBAIX
What is the revenue of GRANDE PHARMACIE DE ROUBAIX ?
The revenue of GRANDE PHARMACIE DE ROUBAIX in 2022 is 2.5 M€.
Is GRANDE PHARMACIE DE ROUBAIX profitable?
Yes, GRANDE PHARMACIE DE ROUBAIX generated a net profit of 115 k€ in 2024.
Where is the headquarters of GRANDE PHARMACIE DE ROUBAIX ?
The headquarters of GRANDE PHARMACIE DE ROUBAIX is located in ROUBAIX (59100), in the department Nord.
Where to find the tax return of GRANDE PHARMACIE DE ROUBAIX ?
The tax return of GRANDE PHARMACIE DE ROUBAIX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE ROUBAIX operate?
GRANDE PHARMACIE DE ROUBAIX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart